Erasca to Present at the Bank of America Securities Health Care Conference
Erasca (Nasdaq: ERAS) will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas.
Rhea-AI Summary
Erasca (Nasdaq: ERAS) will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas. Management will take part in a fireside chat on Wednesday, May 13, 2026 at 3:00 pm PT and hold one-on-one investor meetings.
A live audio webcast will be available at Erasca.com/events, with an archived replay accessible for 30 days after the webcast.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ERAS
On May 6, the day this news came out, ERAS closed 9.11% above the previous close.
Data tracked by StockTitan Argus for the May 6 session.
Key Figures
- Conference date
- May 13, 2026
- Bank of America Securities Health Care Conference fireside chat
- Event time
- 3:00 pm Pacific Time
- Scheduled start time for the fireside chat
- Replay availability
- 30 days
- Archived webcast replay period after the event
Historical Context
-
Positive preliminary Phase 1 ERAS-0015 data in KRAS-mutant solid tumors.
-
Announcement of call and webcast to discuss ERAS-0015 Phase 1 data.
-
Q4/FY25 results with strong cash of $341.8M and extended runway.
-
Option exercised to secure worldwide rights for ERAS-0015, including China.
-
Clinical collaboration with Tango to test ERAS-0015 plus vopimetostat.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
ras/mapk pathway-driven cancers medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities 2026 Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 pm Pacific Time and will also participate in one-on-one investor meetings.
A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.